Diabetes. Diabetic Retinopathy and the Risk of Coronary Heart Disease: The ARIC Study C L I N I C A L I N S I G H T S I N
|
|
- Berenice Johns
- 5 years ago
- Views:
Transcription
1 P r o f e s s i o n a l P o s t g r a d u a t e S e r v i c e s Release Date: August 2007 Valid Until: December 2007 Sponsor This educational activity is a component of the National Diabetes Education Initiative (NDEI ), sponsored by Professional Postgraduate Services (PPS). Professional Postgraduate Services is a business unit of KnowledgePoint360 Group, LLC, Secaucus, NJ. Clinicians who wish to receive CME credit for this educational activity should do the following: (1) read the current issue; and (2) complete the post-test and evaluation form included to conclude this CME activity. You may also complete the post-test andevaluation form on our website, To apply for CME credit,return the completed post-test and evaluation form to: Professional Postgraduate Services CME Dept. T Meadowlands Parkway Secaucus, NJ You may also fax the completed materials to 1 (201) If you have any questions, please call 1 (800) Ext Applicants will receive a certificate of participation from PPS by return mail within 6 to 8 weeks of the date of receipt of the completed evaluation form and post-test. Online applicants will automatically receive their CME credit certificate upon completion of the online post-test and evaluation form. Target Audience This educational activity is designed for primary care physicians, internal medicine specialists, endocrinologists, diabetologists, cardiologists, and other healthcare professionals involved in the care and management of patients with type 2 diabetes, insulin resistance, and cardiovascular disease. Learning Objectives With information from the latest evidencebased studies, participants should be able to: Identify patients with insulin resistance, type 2 diabetes, and/or cardiovascular disease Select the most appropriate therapeutic regimen for patients with type 2 diabetes and its macrovascular and microvascular complications Identify risk factors for cardiovascular disease in patients with type 2 diabetes and select an appropriate therapeutic regimen Accreditation Professional Postgraduate Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Professional Postgraduate Services designates this educational activity for a maximum of.75 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity. Grantor This CME activity is supported by an educational grant from Takeda Pharmaceuticals North America, Inc. Off-Label Disclosure Some of the drug treatments discussed in this issue may note uses not approved by the Food and Drug Administration. Articles containing such uses will be noted at the end of the article. C L I N I C A L I N S I G H T S I N Diabetes V O L U M E 1 0, N U M B E R 8 A U G U S T MAYER B. DAVIDSON, MD,* CO-EDITOR-IN-CHIEF; BERNARD ZINMAN, MD, REVIEWER; TERRENCE F. FAGAN, MANAGING EDITOR AND CO-WRITER; MARK A. PALANGIO, CO-WRITER; MICHELE SALERNITANO, CO-WRITER Diabetic Retinopathy and the Risk of Coronary Heart Disease: The ARIC Study M acrovascular disease is the primary pathogenic mechanism for coronary heart disease (CHD), a leading cause of mortality in patients with type 2 diabetes. Microvascular disease also plays a prominent role in diabetes complications, and diabetic retinopathy is a marker of microvascular disease. To determine if diabetic retinopathy might also be a marker for incident CHD, Cheung and colleagues examined the relation of diabetic retinopathy to incident CHD in a populationbased, prospective cohort of men and women with type 2 diabetes in the Atherosclerosis Risk In Communities (ARIC) Study. The ARIC Study included 15,792 individuals aged 45 to 64 years at first examination between , with a second examination between , and a third between , when retinal photographs were taken of all patients. The 1,524 patients with diabetes in this study had at least 1 retinal photograph gradable according to the Early Treatment of Diabetic Retinopathy Study severity scale, which categorized retinopathy as absent, mild/moderate (nonproliferative), and severe (nonproliferative and proliferative). Patients were free of prevalent CHD and stroke at the time of the retinal photograph. During 7.8 years of follow-up after the retinal photography, the researchers examined incident CHD events in the cohort defined as a fatal CHD event, an incident myocardial infarction (MI), or a myocardial revascularization procedure. They compared unadjusted survival curves by retinopathy levels and determined the hazard rate (HR) ratio for CHD/retinopathy relation using Cox regression, adjusting for sex, race, age, research center, education, diabetes duration and medications, 6-year mean arterial blood pressure, cigarette smoking, antihypertensive treatment, fasting glucose, A1C, body mass index, triglycerides, and total and high-density lipoprotein cholesterol levels. Of the 1,524 participants, 214 (14.7%) had diabetic retinopathy. There were 209 incident CHD events during the 7.8 years of follow-up, including 34 fatal CHD, 110 incident MIs, and 154 cardiac revascularization procedures. After adjusting for multivariate risk factors, diabetic retinopathy was associated with an HR of 2.07 for incident CHD and 3.35 for fatal CHD. CHD risk increased with the severity of retinopathy (HR 1.96 for mild/moderate retinopathy vs HR 2.69 for moderate/severe retinopathy). Diabetic retinopathy was also associated with cardiac revascularization (HR 1.93) and incident MI (HR 1.88), and it remained significant even after adjusting for carotid artery intima-media thickness, inflammatory markers, and nephropathy. The association was significant in men and women with and without hypertension. The authors noted study limitations including the use of one retinal photograph per patient (taken without pharmacologic pupil dilation) for grading, with a high proportion of photographs that couldn t be graded, possibly leading to an underestimation of retinopathy cases. They suggest, however, that a greater number of cases would make the CHD risk stronger in their study. The authors conclude that the study demonstrates an association of diabetic retinopathy with incident CHD independent of diabetes duration and control, cardiovascular risk factors, and large artery atherosclerosis. This supports the concept that microvascular disease may contribute to CHD risk. They suggest that diabetes patients with retinopathy may warrant a more robust cardiovascular assessment and follow-up. Cheung N et al. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007;30: * Dr Davidson is Director, Clinical Center of Research Excellence at Charles R. Drew University, Los Angeles, California. He has indicated the following relevant financial relationships: consultant for Amgen Pharmaceuticals, Amylin Pharmaceuticals, Daiichi Sankyo, Inc. and speaker s bureau member with Amylin Pharmaceuticals, Eli Lilly and Company, and Merck & Co., Inc. Dr Zinman is Director, Leadership Sinai Center for Diabetes, Mt. Sinai Hospital, Toronto, Canada. He has indicated the following relevant financial relationships: grant/research support from Eli Lilly & Company, GlaxoSmithKline, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, and Novo Nordisk A/S; retained consultant for Amylin, Eli Lily & Company, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Pfizer Inc, and Sanofi-Aventis; speaker s bureau for Eli Lilly & Company, GlaxoSmithKline, Merck & Co., Inc., and Novartis Pharmaceuticals Corporation. PPS staff members Managing Editor Terrence Fagan, Senior Medical Writer Mark Palangio, Writer Michele Salernitano, Program Manager Cynthia Fontan, and CME Program Manager Wadee ah Terry have indicated no relevant financial relationships. 1
2 COMMENTARY BERNARD ZINMAN, MD, Director, Leadership Sinai Center for Diabetes, Mt. Sinai Hospital, Toronto, Canada. The article by Cheung et al clearly demonstrates that there is a relationship between microvascular complications, in this case diabetic retinopathy, and coronary heart disease (CHD). Although possible, there is little evidence that this association represents a cause-and-effect relationship between the microvascular and macrovascular complications of diabetes. Rather, there is robust data in type 1 diabetes studies particularly from the DCCT/EDIC (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications) study that glycemic control, as assessed by A1C, plays an important pivotal role in the development of both microvascular and macrovascular diabetes complications. In type 2 diabetes, the traditional cardiovascular risk factors are clearly important determinants of CHD and need to be actively targeted. It is indeed interesting that Cheung et al were able to demonstrate that, after adjusting for traditional risk factors, retinopathy was still associated with CHD. Thus it is conceivable that other nontraditional metabolic determinants are contributing to this association. On-Demand CME Activity at A 54-Year-Old Taxi Driver Who Presents for Reassessment of His Type 2 Diabetes and New Dyspnea on Exertion. For primary care physicians and other healthcare professionals involved in the care of patients with type 2 diabetes. Earn.75 AMA PRA Category 1 Credit Free. On-Demand CME Activity at Incretins and Glycemic Control: Understanding the Science for Better Diabetes Management. For primary care physicians, endocrinologisits, and nurse practitioners. Earn 2.5 AMA PRA Category 1 Credits and 2.4 AANP contact hours Free. Incretin Levels and Effect Are Markedly Enhanced 1 Month After Roux-en-Y Gastric Bypass Surgery in Obese Patients With Type 2 Diabetes S tudies have shown that the majority of patients who undergo bariatric surgery lose 50% to 70% of excess body weight, and 77% of patients who test positive for diabetes before surgery are free of diabetes after surgery. Laferrère and colleagues designed a study to determine the role of incretins in insulin improvement in patients with diabetes who undergo Roux-en-Y gastric bypass surgery (RY-GBP). They selected 8 women patients with a mean age of 45 years with type 2 diabetes of 20.1±12.9 months duration, with a body mass index (BMI) >35 kg/m 2 (obese) and an A1C of 6.9%±0.7%. These patients were not taking insulin, thiazolidinediones, or β-blockers before RY- GBP, or any diabetes medications after surgery. Seven obese women without diabetes and taking no medications were recruited as control subjects, with similar age, body weight, and BMI. Only the women in the diabetes group underwent RY-GBP surgery. Liver enzymes, thyroid function, and blood pressure were measured both at baseline and 1 month after RY-GBP surgery. Baseline measurements showed that fasting and glucose-stimulated levels of glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP) were approximately equivalent between patients with diabetes and control subjects before surgery. GIP is secreted by the K cells in the proximal small intestine, and GLP-1 is secreted by the L cells of the distal small intestine. These 2 incretins affect postprandial insulin secretion and are impaired in patients with diabetes. One month after RY-GBP surgery, a substantial reduction in both body weight (9.2±7.0 kg; P=0.008) and BMI (3.5±3.6 kg/m 2 ; P=0.029) was observed, along with reductions in both fasting glucose (1.60±1.45 mmol/l; P=0.017) and 120-min glucose (4.10±1.62 mmol/l; P<0.0001) levels, which brought the 8 patients with presurgery diabetes into the nondiabetic range. In addition, a substantial increase in insulin levels was shown. During the 1 month directly following the RY-GBP surgery, investigators administered an oral glucose tolerance test (OGTT) and an isoglycemic intravenous glucose test (IsoG IVGT), both consisting of 50 g of glucose, in the morning on 2 separate occasions less than 5 days apart, following a 12-hour overnight fast. Blood was sampled periodically during the 3-hour testing period. OGTT blood samples were compared with those of the IsoG IVGT, and the difference in β-cell responses (measured as insulin total area under the curve [INS area under the curve {AUC} min]) was considered the incretin effect. Analysis found that GLP-1 AUC and peak GIP increased significantly after RY-GBP surgery by 24.3±7.9 pmol 1 1- min -1 (P<0.0001) and 131±85 pg/ml (P=0.007), respectively. A significant increase in the blunted incretin effect, from 7.6%±28.7% to 42.5%±11.3% (P=0.005), was also observed. Investigators concluded that RY-GBP surgery had a very rapid effect on incretin production and activity, occurring less than 1 month after surgery. This incretin effect greatly increased glucose-induced insulin secretion, which resulted in a substantial improvement in diabetes management. Although promising, this study was conducted on a very small group of women with similar ethnic backgrounds. Further testing should be conducted to assess these effects on a larger and more diverse group of participants. Laferrère B et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007;30:
3 NDEI Breakfast Symposium Diabetes Expert Forum The Role of Incretin Therapy in Your Practice Friday, October 5, 2007 Chicago, Illinois 6:00 AM-7:45 AM CME Credit: 1.25 AMA PRA Category 1 Credits TM and 1.25 Prescribed credits. Free registration online at CME/CE Dinner Meeting in Orange ange,, CA for Managed Care Providers Type 2 Diabetes, Metabolic Syndrome, and CVD: Clinical Implications of Recent Pivotal Trials. Date: Wednesday, September 26, 2007 at 6:30 PM. Speaker: Steven V. Edelman, MD. Free registration online at No Impact on All-Cause Mortality With Various Oral Antihyperglycemic Agents Relative to Sulfonylurea P revious work has not revealed a definitive relationship between oral antihyperglycemic drug therapy and mortality. With this in mind, Kahler and colleagues evaluated the impact of several classes of oral antihyperglycemic agents relative to sulfonylurea monotherapy on allcause mortality among a cohort of patients with diabetes from the Veterans Health Administration (VHA). This retrospective cohort study used data obtained from the VHA Diabetes Epidemiology Cohort, which is an ongoing study of virtually all VHA patients with diabetes since October Individuals using oral antihyperglycemic agents were stratified into the following groups: sulfonylurea monotherapy, metformin monotherapy, metformin plus sulfonylurea, thiazolidinedione (TZD) alone or in combination with other oral agents, and no drug therapy. Drug effects on all-cause mortality were estimated using multivariate mixed models. The analysis was restricted to individuals who responded to the 1999 Large Health Survey of Veteran Enrollees (LHSVE) between April 1999 and April Sensitivity analysis odds ratios were adjusted for propensity score plus age, diabetes duration, A1C, creatinine level, diabetes-related physician visits, and utilization of lipid-lowering and hypertension medications. A total of 39,721 patients with diabetes who responded to the LHSVE and received care from 125 US medical facilities were included in the study. Among this study population, 48.0% of patients were in the reference (sulfonylurea monotherapy) group, 7.5% were in the metformin group, 34.8% were in the metformin in combination with sulfonylurea group, 1.7% were in the TZD group, and 8.0% were in the no-drug-therapy group. Mortality rates were 5.3% with sulfonylurea monotherapy, 2.7% with metformin monotherapy, 3.4% with metformin plus sulfonylurea, 7.1% with TZD alone or in combination with other oral agents, and 4.1% with no drug therapy. Adjusted odds ratios and 95% confidence intervals for all-cause mortality were 0.87 ( ) for metformin monotherapy, 0.92 ( ) for metformin plus sulfonylurea, and 1.04 ( ) for TZD, relative to sulfonylurea monotherapy. Adjusting odds ratios without A1C yielded similar findings, indicating the robustness of the original results. This analysis did not reveal any significant drug effect on all-cause mortality for any oral antihyperglycemic therapy relative to oral sulfonylurea monotherapy. The investigators pointed out that this study had the distinctive ability to control for various variables that are usually not available in database studies. Limitations of the study included use of administrative databases and short duration of the follow-up period. Additional study is needed to evaluate whether long-term use of oral antihyperglycemic drug therapy reduces all-cause and cause-specific mortality. Kahler KH et al. Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration. Diabetes Care. 2007;30: AOA/ACOFP 112th Annual Convention & Scientific Seminar Joint ACOFP/AOA Scientific Lecture and Dinner ner Sunday, September 30, 2007 San Diego, California 5:30 PM 9:00 PM CME Hours: 3.5 Extra Credit Register online at: 3 3
4 Clinical Insights in Diabetes Post-Test August ) In the ARIC Study, results showed that diabetic retinopathy was associated with increased risk of: a. Stroke b. Nephropathy c. Coronary heart disease d. Neuropathy 2) In a sub-study focusing on incretin levels in 8 obese women with diabetes, which of the following was an effect in the participants 1 month following Roux-en-Y gastric bypass surgery? a. Significant increase in incretin effects b. Significant decrease in body weight c. Reduction in glucose levels to nondiabetic range d. All of the above 3) Relative to sulfonylurea oral monotherapy, Kahler and colleagues found a significant drug effect on all-cause mortality with: a. Metformin monotherapy b. Thiazolidinedione monotherapy c. Metformin plus sulfonylurea therapy d. No significant drug effect was found ANSWER KEY NDEI MISSION STATEMENT The National Diabetes Education Initiative (NDEI ) is a multicomponent educational program on type 2 diabetes designed for endocrinologists, diabetologists, cardiologists, primary care physicians, and other healthcare professionals involved in the care and management of patients with type 2 diabetes and insulin resistance. NDEI programs address issues concerning insulin resistance and type 2 diabetes, from the epidemiology and pathophysiology of the disease and its associated complications to the therapeutic options for treatment and prevention. National Diabetes Education Initiative, NDEI, and Clinical Insights are trademarks used herein under license. Copyright 2007 Professional Postgraduate Services. All rights reserved. For more information about upcoming NDEI CME and CE activities, visit us at or call 1 (800) Visit for information on other CME or CE activities. Clinical Insights in Diabetes, Monthly is co-edited by NDEI faculty members Mayer B. Davidson, MD, and Silvio E. Inzucchi, MD. Clinical Insights in Diabetes monthly CME e-newsletter is available at no cost to you via . To subscribe to receive future issues via , please visit us online at or insert your name and address below and fax this page back to 1 (800) Name: (Please print) Specialty: Address: You have received this because we believe it may be of interest to you. If you would like your name to be removed from the Clinical Insights newsletter list, please click on the following link EM-T196-5-PHYCME
5 Activity Code: T196-5 Issue Date: August 2007 CME Credit Availability: Through December 2007 CME Activity Evaluation/Registration Form Participants who wish to obtain CME credit for this educational activity, please complete the contact information below, sign this form, and fax it with the completed post-test to 1 (201) or mail to: Professional Postgraduate Services, CME Dept. T196, 150 Meadowlands Parkway, Secaucus, NJ You may download previous issues of Clinical Insights in Diabetes e-newsletters by visiting us online at I have completed this activity as designed: (Signature) PLEASE PRINT CLEARLY: Name: Address: City: Phone: Address: State: ZIP Code: - - Fax: - - Professional Classification: MD DO PharmD RN NP Other Specialty: Endocrinology Cardiology Internal medicine Family medicine Other 1. The activity met the stated objectives in such a way that I am better able to: a. Identify patients with insulin resistance, type 2 diabetes, and/or cardiovascular disease b. Select the most appropriate therapeutic regimen for patients with type 2 diabetes and its macrovascular and microvascular complications c. Identify risk factors for cardiovascular disease in patients with type 2 diabetes and select an appropriate therapeutic regimen Strongly Disagree Disagree Agree Strongly Agree 2. Overall, the activity was presented in a fair-balanced manner. Yes No* * If you checked No, please explain. 3. Overall, the activity was free from commercial bias. Yes No* * If you checked No, please explain. 4. In reflecting on your practice, what type of impact will this educational activity have? This program has validated my practice in the treatment of type 2 diabetes and its cardiovascular complications. Need more information before making a change. (Please specify what information you would require.) 5. What is the largest challenge or unmet educational need in your practice? 6. What other clinical issues are you and your colleagues challenged by that could be addressed in a CME activity? (Please specify.) Thank you for your participation. 5 5
Diabetes MAYER B. DAVIDSON, MD,* CO-EDITOR-IN-CHIEF; HENRY N. GINSBERG, MD, REVIEWER; TERRENCE F. FAGAN, MANAGING EDITOR; CHING-LING CHEN, PhD, WRITER
Professional Postgraduate Services Release Date: March 14, 2008 Valid Through: July 14, 2008 Sponsor This educational activity is a component of the National Diabetes Education Initiative (NDEI ), sponsored
More informationMortality Rates Reduced in Men but Not in Women With Diabetes, 1971 to 2000
P r o f e s s i o n a l P o s t g r a d u a t e S e r v i c e s Release Date: September 2007 Valid Until: January 2008 Sponsor his educational activity is a component of the National Diabetes Education
More informationCME/CE QUIZ CME/CE QUESTIONS
CME/CE QUIZ CME/CE QUESTIONS Continuing Medical Education Accreditation The University of Cincinnati College of Medicine designates this educational activity for a maximum of two (2) AMA PRA Category 1
More informationA Comprehensive Strategy on the Modern Management of Type 1 and Type 2 Diabetes
11 TH YEAR IN A UNIQUE NATIONAL SERIES A Comprehensive Strategy on the Modern Management of Type 1 and Type 2 Diabetes MEDICAL EDUCATION FOR HEALTHCARE PROFESSIONALS Making the Connection Between Patients
More informationDiabetes: A Cardiovascular Disease Current Approaches to Treatment A Continuing Education Program
Diabetes: A Cardiovascular Disease Current Approaches to Treatment A Continuing Education Program Sponsored by: Blue Cross and Blue Shield of New Mexico and New Mexico Health Care Takes On Diabetes Objectives:
More informationA Clinical Context Report
Type 2 Diabetes in Practice An Expert Commentary with Silvio E. Inzucchi, MD A Clinical Context Report Clinical Context: Type 2 Diabetes in Practice Expert Commentary Jointly Sponsored by: and Clinical
More information... CME/CPE QUIZ... CME/CPE QUESTIONS
CME/CPE QUESTIONS Continuing Medical Education Accreditation The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 credit hours in category 1 credit toward
More informationMaking the Connection
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, May 5, 2018 Hawaii Convention Center
More informationBY BERNARD ZINMAN, MD
Understanding the Relationship Between Hyperglycemia and Microvascular Complications Jointly sponsored by The Dulaney Foundation and DIABETIC MICROVASCULAR COMPLICATIONS TODAY. Release Date: August 2006.
More informationSATURDAY FEBRUARY 23, 2013
MAKING THE CONNECTION 8th 7th Year in a Unique National Series Improving Clinical Care and Adherence for Patients with Diabetes SATURDAY FEBRUARY 23, 2013 Tucson Convention Center Tucson, Arizona Continuing
More informationFebruary 13-15, 2009 Ft. Lauderdale, FL
PRI-MED SYMPOSIA Pri-Med South CONFERENCE & EXHIBITION February 13-15, 2009 Ft. Lauderdale, FL Earn up to 17 AMA PRA Category 1 Credit(s) Pre-Conference Symposia Day Schedule Thursday, February 12, 2009
More informationType 2 Diabetes in Practice. An Expert Commentary with Farhad Zangeneh, MD, FACP, FACE A Clinical Context Report
Type 2 Diabetes in Practice An Expert Commentary with Farhad Zangeneh, MD, FACP, FACE A Clinical Context Report Clinical Context: Type 2 Diabetes in Practice Expert Commentary Jointly Sponsored by: and
More informationType 1 Diabetes: New and Emerging Therapeutic Strategies to Address Unmet Needs
A CME REGIONAL MEETING SERIES Type 1 Diabetes: New and Emerging Therapeutic Strategies to Address Unmet Needs Thursday, March 7, 2019 Halekulani Hotel Honolulu, Hawaii THIS ACTIVITY IS JOINTLY PROVIDED
More informationMaking the Connection Between Patients and Providers
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, April 27, 2019 Hawaii Convention Center
More informationMaking the Connection
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, March 17, 2018 Monterey Conference
More informationMaking the Connection
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, February 3, 2018 William A. Egan Civic
More informationENDOCRINOLOGY FOR PRIMARY CARE: Hilton Head Island, South Carolina Hilton Head Marriott Resort & Spa August 9 12, 2018
ENDOCRINOLOGY FOR PRIMARY CARE: Hilton Head Island, South Carolina Hilton Head Marriott Resort & Spa August 9 12, 2018 Thursday, August 9th: 7:00 am 7:30 am Registration and Hot Breakfast 7:30 am 8:30
More informationHealthcare Implications of Achieving JNC 7 Blood Pressure Goals in Clinical Practice
CONTINUING EDUCATION Healthcare Implications of Achieving JNC 7 Blood Pressure Goals in Clinical Practice GOAL To provide participants with current information about current blood pressure goals and effective
More informationThe Arthur C. Nielsen, Jr. Vascular Symposium: A Clinical Update on Vascular Medicine and Surgery
The Arthur C. Nielsen, Jr. Vascular Symposium: A Clinical Update on Vascular Medicine and Surgery Chicago, Illinois March 7, 2014 Sponsored by: of GENERAL INFORMATION The s Center for Vascular Disease
More informationHealth Delivery and Technology in Today s DIABETES CARE
Health Delivery and Technology in Today s DIABETES CARE Applying Evidence Based Treatments to Personalized Care The Inn at St. John s. Plymouth, MI The 2018 Diabetes Care conference is sponsored by Grand
More informationDIABETES and CANCER 2017:
Symposium on DIABETES and CANCER 2017: Novel Links and Treatments Friday, April 7, 2017 New York Academy of Medicine 1216 Fifth Avenue (at 103rd Street) 10029 Course Directors Professor of Medicine, Interim
More informationPractical Strategies for the Clinical Use of Incretin Mimetics CME/CE. CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010
Practical Strategies for the Clinical Use of Incretin Mimetics CME/CE Robert R. Henry, MD Authors and Disclosures CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010 Introduction Type 2 diabetes
More informationCME Post Test. D. Treatment with insulin E. Age older than 55 years
CME Post Test Translational Endocrinology & Metabolism: Metabolic Surgery Update Please select the best answer to each question on the online answer sheet. Go to http://www.endojournals.org/translational/
More informationPROGRAM SYLLABUS. Jointly provided by Potomac Center for Medical Education and Rockpointe
PROGRAM SYLLABUS Jointly provided by Potomac Center for Medical Education and Rockpointe This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding
More informationA CME Regional Meeting Series Comparing and Contrasting Basal Insulin Strategies
A CME Regional Meeting Series Comparing and Contrasting Basal Insulin Strategies In Type 1 and Type 2 Diabetes Thursday, August 2, 2018 Sheraton Grand Sacramento, Sacramento, California TCOYD is a 501(c)3
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More informationCardiovascular Benefits of Two Classes of Antihyperglycemic Medications
Cardiovascular Benefits of Two Classes of Antihyperglycemic Medications Nathan Woolever, Pharm.D., Resident Pharmacist Pharmacy Grand Rounds November 6 th, 2018 Franciscan Healthcare La Crosse, WI 2017
More informationENDOCRINOLOGY FOR PRIMARY CARE
ENDOCRINOLOGY FOR PRIMARY CARE Las Vegas, Nevada The Cosmopolitan February 27 March 1, 2015 Participating Faculty Gregory A. Brent, MD Professor, Departments of Medicine and Physiology David Geffen School
More informationReduced Carbohydrate Intake May Lower Cardiovascular Risk CME
To Print: Click your browser's PRINT button. NOTE: To view the article with Web enhancements, go to: http://www.medscape.com/viewarticle/516977 This activity is supported by funding from WebMD. Reduced
More informationMELANIE VISALLI, MANAGING EDITOR AND WRITER
CLINICAL INSIGHTS IN Volume 13, Issue 5 December 2012 Learning Objectives Summarize data comparing two long-acting glucagon-like peptide-1 receptor agonists for type 2 diabetes treatment Discuss data exploring
More informationCLINICAL ENDOCRINOLOGY FOR PRIMARY CARE
CLINICAL ENDOCRINOLOGY FOR PRIMARY CARE Walt Disney World Resort, Florida Disney s Grand Floridian Resort & Spa November 14 16, 2014 Participating Faculty Veronica Piziak, MD, PhD Professor of Medicine
More informationObesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes
Obesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes Genetics, environment, and lifestyle (obesity, inactivity, poor diet) Impaired fasting glucose Decreased β-cell
More informationWhy is Earlier and More Aggressive Treatment of T2 Diabetes Better?
Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:
More informationThe Many Faces of T2DM in Long-term Care Facilities
The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment
More informationGERIATRIC MEDICINE FOR PRIMARY CARE: NEUROLOGY/PALLIATIVE CARE/RHEUMATOLOGY. San Diego, California Hotel del Coronado October 26 28, 2018
GERIATRIC MEDICINE FOR PRIMARY CARE: NEUROLOGY/PALLIATIVE CARE/RHEUMATOLOGY San Diego, California Hotel del Coronado October 26 28, 2018 Friday, October 26th: 7:00 am 7:30 am Registration and Hot Breakfast
More informationGERIATRIC MEDICINE FOR PRIMARY CARE. Chicago, Illinois The Gwen, A Luxury Collection Hotel, Chicago June 22 24, 2018
GERIATRIC MEDICINE FOR PRIMARY CARE Chicago, Illinois The Gwen, A Luxury Collection Hotel, Chicago June 22 24, 2018 Friday, June 22nd: 7:30 am 8:00 am Registration and Hot Breakfast 8:00 am 9:00 am Faculty
More informationCARDIOLOGY & PULMONOLOGY FOR PRIMARY CARE. Yosemite, California Tenaya Lodge at Yosemite September 21 23, 2018
CARDIOLOGY & PULMONOLOGY FOR PRIMARY CARE Yosemite, California Tenaya Lodge at Yosemite September 21 23, 2018 Friday, September 21st: 7:00 am 7:30 am Registration and Hot Breakfast 7:30 am 8:30 am Cardiology
More informationCARDIOLOGY & PULMONOLOGY FOR PRIMARY CARE. Asheville, North Carolina The Omni Grove Park Inn May 18 20, 2018
CARDIOLOGY & PULMONOLOGY FOR PRIMARY CARE Asheville, North Carolina The Omni Grove Park Inn May 18 20, 2018 Friday, May 18th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary
More informationADVANCES IN PARKINSON S DISEASE: A MULTIDISCIPLINARY APPROACH SATURDAY, OCTOBER 7, :30 A.M. 5:00 P.M.
ADVANCES IN PARKINSON S DISEASE: A MULTIDISCIPLINARY APPROACH SATURDAY, OCTOBER 7, 2017 7:30 A.M. 5:00 P.M. This conference will explore the challenges and opportunities facing clinicians and healthcare
More informationPain: State-of-the-Art Psychiatric and Medical Management
Pain: State-of-the-Art Psychiatric and Medical Management 7:15 A.M. - 4:30 P.M. Psychiatrists, internists, hospitalists, pain management specialists, family physicians, primary care physicians, and allied
More informationA Clinical Context Report
Stroke Prevention in Atrial Fibrillation An Expert Commentary With Kenneth W. Mahaffey, MD A Clinical Context Report Stroke Prevention in Atrial Fibrillation Expert Commentary Jointly Sponsored by: and
More informationDiabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?
Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of
More information13th Annual Women and Ischemic Heart Disease Symposium Friday, May 10, 2019
13th Annual Women and Ischemic Heart Disease Symposium Friday, May 10, 2019 COURSE DIRECTOR C. Noel Bairey Merz, MD, FACC CONFERENCE LOCATION Cedars-Sinai Medical Center Harvey Morse Conference Center
More informationUnderstanding the Mechanisms to Maintain Glucose
n posttest n Understanding the Mechanisms to Maintain Glucose Homeostasis: A Review for Managed Care Instructions After reading Understanding the Mechanisms to Maintain Glucose Homeostasis: A Review for
More informationLIVER DISEASE WRAP-UP
20th Annual LIVER DISEASE WRAP-UP An Update on Advances in Clinical Hepatology An update on advances in clinical hepatology presented at the 2017 AASLD Meeting for Practicing Internists, Gastroenterologists,
More informationWOMEN S HEALTH FOR PRIMARY CARE. San Diego, California Hotel del Coronado August 10 13, 2017
WOMEN S HEALTH FOR PRIMARY CARE San Diego, California Hotel del Coronado August 10 13, 2017 Thursday, August 10th: 7:30 am 8:00 am Registration and Hot Breakfast 8:00 am 9:00 am Gynecology Abnormal Uterine
More informationAbbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone
Index Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication GAD glutamic acid decarboxylase GLP-1 glucagon-like peptide 1 NPH neutral
More informationBarriers to Achieving A1C Targets: Clinical Inertia and Hypoglycemia. KM Pantalone Endocrinology
Barriers to Achieving A1C Targets: Clinical Inertia and Hypoglycemia KM Pantalone Endocrinology Disclosures Speaker Bureau AstraZeneca, Merck, Novo Nordisk, Sanofi Consultant Novo Nordisk, Eli Lilly, Merck
More informationResults from the Risk and Prevention Study showed no effect of omega-3. Findings from ORIGIN-GRACE showed no statistically
VOLUME 14, ISSUE 2 JULY 2013 MELANIE VISALLI, MANAGING EDITOR AND WRITER No Difference in Annualized CIMT Change in ORIGIN-GRACE Findings from ORIGIN-GRACE showed no statistically signifi cant difference
More informationSoliqua (insulin glargine and lixisenatide), Xultophy (insulin degludec and liraglutide)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.48 Subject: Insulin GLP-1 Combinations Page: 1 of 5 Last Review Date: September 15, 2017 Insulin GLP-1
More informationFINAL ENDURING OUTCOMES REPORT
FINAL ENDURING OUTCOMES REPORT OVERVIEW This report summarizes consolidated outcomes data from an enduring satellite symposium activity that was launched In March 2017 and ran for 12 months, cumulatively,
More informationSleep Disorders and Excessive Sleepiness: Impact on Quality of Life
CME/CE POSTTEST Sleep Disorders and Excessive Sleepiness: Impact on Quality of Life CME Information Program Overview Excessive sleepiness is a complaint found in patients who experience sleepiness at unwanted
More information20th Annual Conference. Frontiers in Diabetes Research: Biological Bases for Complications of Diabetes
20th Annual Conference Frontiers in Diabetes Research: Biological Bases for Complications of Diabetes Saturday, November 17, 2018 Course Directors Domenico Accili, M.D., Russell Berrie Foundation Professor
More informationNEUROLOGY FOR PRIMARY CARE. San Diego, California Hotel del Coronado August 9 12, 2018
NEUROLOGY FOR PRIMARY CARE San Diego, California Hotel del Coronado August 9 12, 2018 Thursday, August 9th: 7:00 am 7:30 am Registration and Hot Breakfast 7:30 am 8:30 am Faculty 1 The Neurological Exam
More informationHispanic Women s Heart Health Today:
Hispanic Women s Heart Health Today: Applying the Guidelines Toward Hispanic Heart Healthy Initiatives Saturday, October 6, 2012 Montefiore Moses Campus Tishman Learning Center 111 East 210th Street Bronx,
More informationEarning, redeeming and merging CME/CE/CPD credit
UpToDate Earning, redeeming and merging CME/CE/CPD credit A step-by-step guide for clinicians accessing UpToDate through an EHR, clinician portal or other secure clinical system GET STARTED EARNING CME/CE/CPD
More informationChallenges in type 2 diabetes control: slipping control and weight gain
control Earn 3 CPD Points online Case study Challenges in type 2 diabetes control: slipping control and weight gain Presenter Dr Sedeshan Govender Specialist Physician, Endocrinologist and Diabetologists
More informationUPDATES IN NEPHROLOGY FOR THE PRIMARY CARE PROVIDER SATURDAY, MAY 5, 2018 THE INN AT ST. JOHN S, PLYMOUTH, MI
UPDATES IN NEPHROLOGY FOR THE PRIMARY CARE PROVIDER SATURDAY, MAY 5, 2018 THE INN AT ST. JOHN S, PLYMOUTH, MI program schedule 7:30 am Registration and Continental Breakfast 8:00 Welcome and Introduction
More informationNEXT GENERATION MIGRAINE THERAPIES. Saturday, April 6, 2019 Sheraton San Diego Hotel & Marina-Bay Tower San Diego, California
Saturday, April 6, 2019 Sheraton San Diego Hotel & Marina-Bay Tower San Diego, California Saturday, May 18, 2019 Westin Galleria Dallas Dallas, Texas Saturday, June 8, 2019 Marriott Marquis New York New
More informationHanyang University Guri Hospital Chang Beom Lee
Hanyang University Guri Hospital Chang Beom Lee Meal prayer, Van Brekelenkam 17 th C Introduction 2012 ADA/EASD Position Statement Proper Patients for Pioglitazone β-cell Preservation by Pioglitazone Benefit
More informationGlucagon-like peptide-1 (GLP-1) Agonists Drug Class Prior Authorization Protocol
Glucagon-like peptide-1 (GLP-1) Agonists Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed
More informationActivity Evaluation Summary
Activity Evaluation Summary CME Activity: Experts on Call: Current Issues in the Management of Osteoporosis, 2013-2014 Dates: December 2, 2013 December 17, 2013 January 27, 2014 Format: Course Director:
More informationExpert Perspectives. December 13, 2008 New York City. Acute and Maintenance. Treatment of Bipolar Disorder:
Acute and Maintenance Treatment of Bipolar Disorder: Expert Perspectives December 13, 2008 New York City Sponsored by the NYU Post-Graduate Medical School The Post-Graduate Medical School of the New York
More information9th Annual Orange County Symposium on Cardiovascular Disease Prevention
The Division of Cardiology, Department of Medicine, UC Irvine School of Medicine Presents the 9th Annual Orange County Symposium on Cardiovascular Disease Prevention Future Directions in Prevention of
More informationCENTER FOR CONTINUING & OUTREACH EDUCATION. 30 Bergen St. ADMC 710 Newark, NJ
Non-Profit CCOE Organization U.S. Postage CENTER FOR CONTINUING & OUTREACH EDUCATION PAID UMDNJ CENTER FOR CONTINUING & OUTREACH EDUCATION 30 Bergen St. ADMC 710 Newark, NJ 07107-3000 ADVANCES IN CARDIOVASCULAR
More informationHeart Rate in Patients with Coronary Artery Disease - the Lower the Better? An Analysis from the Treating to New Targets (TNT) trial
Heart Rate in Patients with Coronary Artery Disease - the Lower the Better? An Analysis from the Treating to New Targets (TNT) trial Sripal Bangalore, MD, MHA, Chuan-Chuan Wun, PhD, David A DeMicco, PharmD,
More informationTCOYD Regional Meeting Series Comparing and Contrasting Basal Insulin Strategies
TCOYD Regional Meeting Series Comparing and Contrasting Basal Insulin Strategies In Type 1 and Type 2 Diabetes Thursday, May 17, 2018 Loews Vanderbilt Hotel Nashville, Tennessee TCOYD is a 501(c)3 nonprofit
More informationGlucose Control and Prevention of Cardiovascular Disease
Glucose Control and Prevention of Cardiovascular Disease Dr Peter A Senior BMedSci MBBS PhD FRCP(E) Associate Professor, Director Division of Endocrinology, University of Alberta Diabetes Update+, March
More informationApril 5-10, Primary Care Medicine: Update Wailea Beach Marriott Hotel Maui, Hawaii
Division of General Internal Medicine Department of Medicine University of California, San Francisco, School of Medicine University of California San Francisco Primary Care Medicine: Update 2015 SUNDAY
More information4 TH ANNUAL WOMEN S CARDIOVASCULAR HEALTH CONFERENCE
Sponsored by: The Ohio State University Wexner Medical Center in cooperation with Ohio State s Heart and Vascular Center and the Division of Cardiovascular Medicine 4 TH ANNUAL WOMEN S CARDIOVASCULAR HEALTH
More informationOPTIMAL CARE AND NEW THERAPIES FOR ADVANCED HEART DISEASE
OPTIMAL CARE AND NEW THERAPIES FOR This program is endorsed by the California Chapter of the American College of Cardiology SATURDAY, MAY 11, 2013 HYATT REGENCY LONG BEACH T H I S P R O G R A M I S S P
More informationPEDIATRIC & ADOLESCENT MEDICINE FOR PRIMARY CARE: ENDOCRINOLOGY/GYNECOLOGY/INFECTIOUS DISEASE. Scottsdale, Arizona The Phoenician February 8 10, 2019
PEDIATRIC & ADOLESCENT MEDICINE FOR PRIMARY CARE: ENDOCRINOLOGY/GYNECOLOGY/INFECTIOUS DISEASE Scottsdale, Arizona The Phoenician February 8 10, 2019 Friday, February 8th: 7:00 am 7:30 am Registration and
More informationAdult Diabetes Clinician Guide NOVEMBER 2017
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Diabetes Clinician Guide Introduction NOVEMBER 2017 This evidence-based guideline summary is based on the 2017 KP National Diabetes Guideline.
More informationA factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
A factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Hypotheses: Among individuals with type 2 diabetes, the risks of major microvascular
More informationCardiovascular Update for the Primary Care Provider. Friday, June 12, 2015 Seattle
virginia mason continuing medical education Cardiovascular Update for the Primary Care Provider Friday, June 12, 2015 Seattle Faculty course director: J. Susie Woo, MD, FACC The Heart Institute at Virginia
More informationCurrent Updates & Challenges In Managing Diabetes in CVD
Current Updates & Challenges In Managing Diabetes in CVD Preventive Cardiovascular Conference 2016 Instituit Jantung Negara 12 th November 2016 Nor Azmi Kamaruddin Diabetes Clinic Department of Medicine
More informationDIABETES UPDATE and ADVANCES IN ENDOCRINOLOGY AND METABOLISM
Divisions of Endocrinology and Metabolism Department of Medicine University of California, San Francisco School of Medicine DIABETES UPDATE and ADVANCES IN ENDOCRINOLOGY AND METABOLISM Thursday - Saturday,
More informationCARDIOVASCULAR RISK REDUCTION
Jointly provided by the NYU Post-Graduate Medical School, the New York Chapter of the American College of Physicians and the Northeast Lipid Association Co-organized by the Division of Cardiology and the
More informationArnold and Mabel Beckman Center of the National Academies of Sciences and Engineering. 100 Academy Way, Irvine, CA 92617
LOCATION PROGRAM 7:30 am REGISTRATION & CONTINENTAL BREAKFAST 8:00 am Welcome 8:10 am Introductory Remarks Ralph V. Clayman, MD Dean, UC Irvine School of Medicine Ischemic Stroke and TIA 8:20 am Pre-Hospital
More informationFRIDAY, MAY 12, TH ANNUAL WOMEN AND ISCHEMIC HEART DISEASE SYMPOSIUM
11 TH ANNUAL WOMEN AND ISCHEMIC HEART DISEASE SYMPOSIUM Offered in cooperation with the California Chapter of the American College of Cardiology and WomenHeart: The National Coalition for Women with Heart
More informationCedars-Sinai Medical Center Harvey Morse Conference Center Plaza Level, South Tower 8701 Gracie Allen Drive Los Angeles, CA 90048
10 th Annual Women and Ischemic Heart Disease Symposium Friday, May 13, 2016 Offered in cooperation with the California Chapter of the American College of Cardiology and WomenHeart: The National Coalition
More informationThis article is a CME/CE certified activity. To earn credit for this activity visit:
Novel Perspectives on Type 2 Diabetes: Traditional and Emerging Therapies and the Potential Role of the Kidneys This article is a CME/CE certified activity. To earn credit for this activity visit: www.medscape.org/lecture/t2dm-therapies
More informationPractical Update in Cardiology 2017
Practical Update in Cardiology 2017 A Comprehensive Review of the Latest Breakthroughs and Advances in Cardiovascular Medicine from a Practical Viewpoint Saturday, Nov. 11 Detroit Marriott Troy Troy, Michigan
More informationColorectal. The Latest Advances to Improve Adenoma Detection Rates. Sunday, October 15, 2017
Presorted First Class Mail US Postage PAID Permit # 906 Bellmawr NJ Cancer Prevention Distinguished Indiana University Indianapolis, IN University of Kansas School of Medicine Kansas City, MO Editor in
More informationGeriatrics For Primary Care Providers
Excellence. Compassion. Longevity Geriatrics For Primary Care Providers SATURDAY, JUNE 23, 2018, 8 a.m. 4 p.m. MD Anderson Mitchell Basic Science Research Building Onstead Auditorium, 3rd Floor 6767 Bertner
More information2014 APPNA Florida Chapter Fall CME
Faculty Name: Asad Shaikh, MD ASSOCIATION OF PHYSICIANS OF PAKISTANI-DESCENT OF NORTH AMERICA CME Evaluation Presentation Title: Diagnosis and Prevention of Breast Cancer 2014 APPNA Florida Chapter Fall
More informationNEUROLOGY FOR PRIMARY CARE. Sea Island, Georgia The Cloister at Sea Island September 29 October 2, 2016
NEUROLOGY FOR PRIMARY CARE Sea Island, Georgia The Cloister at Sea Island September 29 October 2, 2016 Thursday, September 29th: 7:30 am 8:00 am Registration and Breakfast 8:00 am 9:00 am Faculty 1 The
More informationFixed dose combination for Trusted Diabetes Control Lobna Farag Eltooy Head of Internal Medicine Department Assiut University
Fixed dose combination for Trusted Diabetes Control By Lobna Farag Eltooy Head of Internal Medicine Department 1 Assiut University 3/18/2018 3/18/2018 3/18/2018 Diabetes Complications with Increasing HbA1c
More informationChanging Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer
Saturday, October 27, 2018 7:00 AM - 3:45 PM Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer Program Director John V.
More informationNEUROLOGY FOR PRIMARY CARE. Las Vegas, Nevada The Cosmopolitan May 11 13, 2018
NEUROLOGY FOR PRIMARY CARE Las Vegas, Nevada The Cosmopolitan May 11 13, 2018 Friday, May 11th: 7:30 am 8:00 am Registration and Hot Breakfast 8:00 am 9:00 am Faculty 1 The Neurological Exam Characteristics
More informationHot Topics in. Thursday, October 5, Register Online! VindicoCME.com/ CASE CHOICE. Interactive Dinner Symposium 2.0.
Clinical Chief, /-certified Activity /-certified Activity This continuing Audience-driven, -based Learning Customized learning at your fingertips you choose case! Overview Agenda Antiretroviral rapy has
More informationComprehensive Stroke & Cerebrovascular Center Symposium. From Acute Care to Brain Recovery. Saturday, Oct. 8, 2016
Comprehensive Stroke & Cerebrovascular Center Symposium From Acute Care to Brain Recovery Saturday, Oct. 8, 2016 The Westin South Coast Plaza 686 Anton Blvd., Costa Mesa, CA 92626 Register online: www.neurology.uci.edu/stroke-cme
More informationCourse Description. Target Audience. Learning Objectives
Course Description The UC Irvine Stroke & Cerebrovascular Center Symposium offers an update on the latest advances in the management of stroke care and surgical and endovascular intervention, prevention
More informationADVANCES IN CARDIOVASCULAR DIAGNOSIS & THERAPY. Radisson Hotel & Conference Center st Avenue, Coralville, Iowa
5 th Annual ADVANCES IN CARDIOVASCULAR DIAGNOSIS & THERAPY FRIDAY, APRIL 27, 2018 Radisson Hotel & Conference Center 1220 1st Avenue, Coralville, Iowa Provided by: Department of Internal Medicine, Division
More informationMore Diabetes Potpourri : Additional Current Issues Related to Diabetes
Page 1 Scott K. Stolte, Pharm.D. Associate Dean for Academic Affairs Bernard J. Dunn School of Pharmacy Shenandoah University This program has been brought to you by PharmCon Accreditation: Pharmacists:
More informationUROLOGIC CANCER UPDATE
UROLOGIC CANCER UPDATE SATURDAY, JUNE 10, 2017 7:30 A.M. 1:00 P.M. This activity is intended for urologists, primary care physicians, and allied healthcare professionals responsible for overseeing the
More informationGLP 1 agonists Winning the Losing Battle. Dr Bernard SAMIA. KCS Congress: Impact through collaboration
GLP 1 agonists Winning the Losing Battle Dr Bernard SAMIA KCS Congress: Impact through collaboration CONTACT: Tel. +254 735 833 803 Email: kcardiacs@gmail.com Web: www.kenyacardiacs.org Disclosures I have
More information